KogaMSerritellaAVMessmerMMHayashi-TakagiAHesterLDSnyderSHet al
It is currently in Phase 3 for alcohol use disorder (the RENEW-ALC-1 and RENEW-ALC-2 trials, 1,100 patients each) and in earlier-stage development for bipolar disorder, major depressive disorder, smoking withdrawal, asthma, cardiovascular and liver disorders, and obesity
A 1.0mL syringe with 2-unit markings only measures to 2 units, which at 10mg/mL equals 0.2mg precision
Three amino acid-altering GIP receptor variants (R190Q, E288G, and E354Q) are all associated with lower bone mineral density, and in postmenopausal women followed for 10 years, who were homozygous carriers of the E354Q variant, showed a higher risk of non-vertebral fractures (99, 101)